[1]
Y. Xu, “Predictive Value of Tumor-Infiltrating Lymphocytes for Neoadjuvant Chemotherapy Among Triple-Negative Breast Cancer”, IJBLS, vol. 17, no. 2, pp. 32–36, Nov. 2026, doi: 10.54097/j931ky70.